Cost-Effectiveness Analysis of Perioperative Oral Management after Cancer Surgery and an Examination of the Reduction in Medical Costs Thereafter: A Multicenter Study
| Autor: | Masaru Ohashi, Akihide Negishi, Hideki Sekiya, Yukihiro Michiwaki, Yutaka Kobayashi, Hitoshi Mukohyama, Masayuki Ueno, Shiro Shigematsu, Yasuhiro Kurasawa, Shiro Hasegawa, Junpei Sugizaki, Yutaka Maruoka |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
animal structures Cost-Benefit Analysis Health Toxicology and Mutagenesis Administration Oral 030230 surgery Article 03 medical and health sciences 0302 clinical medicine Neoplasms Health care perioperative oral management Humans incremental cost-effectiveness ratio Medicine 030212 general & internal medicine health care economics and organizations oral care business.industry Incidence (epidemiology) Public Health Environmental and Occupational Health incidence of postoperative pneumonia Health Care Costs Pneumonia Perioperative Cost-effectiveness analysis medicine.disease effect of reducing healthcare cost Emergency medicine sense organs cancer surgery business Medical costs Incremental cost-effectiveness ratio Cancer surgery |
| Zdroj: | International Journal of Environmental Research and Public Health, Vol 18, Iss 7453, p 7453 (2021) International Journal of Environmental Research and Public Health Volume 18 Issue 14 |
| ISSN: | 1660-4601 |
| DOI: | 10.3390/ijerph18147453 |
| Popis: | In April 2012, perioperative oral management (POM) was approved for inclusion in the national health insurance system of Japan to prevent the occurrence of pneumonia, a major complication in cancer patients. The subsequent decrease in the incidence of postoperative pneumonia indicated the prophylactic effect of POM. The constant increase in health expenditure necessitates a cost-effectiveness analysis. In addition, the effect of reducing healthcare costs owing to health technologies must be evaluated. In the present multi-institutional study, the cost-effectiveness analysis of POM was conducted by comparing the incidence of postoperative pneumonia and the healthcare costs between patients who received surgery for malignant tumors before (n = 11,886) and after (n = 13,668) the introduction of POM. Additionally, the effect of reducing healthcare costs was evaluated. Reductions in the number of patients who developed pneumonia, duration of hospitalization, and number of deaths were observed after the introduction of POM. The incremental cost-effectiveness ratio was 111,927 yen, hence the prevention of postoperative pneumonia needs 111,927 yen per patient in healthcare costs. Consequently, a maximum reduction of 250,368,129 yen in healthcare costs was observed between the incremental costs for pneumonia treatment and the cost of POM. These findings indicate that improvements in cost-effectiveness can be expected in the future through the development of procedure and system for POM. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|